Brief: Bellicum Pharmaceuticals posts Q3 net loss $17.7 million
09/11/2016 21:33
Nov 9 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O
* Says Q3 net loss of $17.7 million versus $13.4 million
Source text: (http://bit.ly/2eULOVg)
Further company coverage: BLCM.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview